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        Introduction 
  Voltage-gated sodium channels (Na  v  ) are responsible for the 
normal electrical activity of excitable cells, including neurons, 
skeletal muscle, and cardiomyocytes (  Burgess et al., 1995  ;   Cannon, 
1996  ;   Escayg et al., 2000  ;   Keating and Sanguinetti, 2001  ;   Lossin 
et al., 2002  ;   Papadatos et al., 2002  ;   Yu et al., 2005  ). Na  v 1.5  (en-
coded by  SCN5A ) is the principal Na  v  channel in vertebrate heart. 
Na  v  1.5-dependent activity underlies the rapid upstroke of the 
cardiac action potential (  Keating and Sanguinetti, 2001  ). Na  v 1.5 
activity depends on precise biophysical properties that regulate 
inward Na 
+   current in response to cardiomyocyte membrane po-
tential. Human   SCN5A   variants that affect biophysical properties 
of Na  v  1.5 are associated with several potentially fatal arrhyth-
mias, including type 3 long QT syndrome (LQT3; variants 
  increase inward Na 
+   current) and Brugada Syndrome (variants 
reduce inward Na 
+   current;   Priori, 2004  ;   Shah et al., 2005  ). 
  In addition to normal biophysical properties, Na  v 1.5  activ-
ity requires proper localization at specialized cardiomyocyte 
membrane domains. In the vertebrate heart, Na  v  1.5 is primarily 
concentrated at the cardiomyocyte intercalated disc (  Kucera 
et al., 2002  ;   Maier et al., 2002  ;   Mohler et al., 2004b  ). However, 
Na  v  1.5 localization at the peripheral sarcolemma and T tubules 
has also been described previously (  Cohen, 1996  ;   Scriven et al., 
2000, 2002; Kucera et al., 2002  ). The molecular mechanisms un-
derlying the targeting and retention of Na  v  1.5 in cardiac tissue are 
unknown. Over the past decade, several potential Na  v 1.5  inter-
molecular interactions have been hypothesized to regulate Na  v 1.5 
membrane traffi  cking, stability, and removal (  Herfst et al., 2004; 
Abriel and Kass, 2005  ). However, the roles for these protein 
interactions in the context of a cardiomyocyte are unclear. 
  Ankyrin-G is an adaptor protein required for the targeting 
of diverse membrane proteins in the central nervous system 
(  Mohler and Bennett, 2005b  ). Specifi  cally, ankyrin-G is re-
quired for the targeting of Na  v   channel isoforms (Na  v 1.2  and 
Na  v  1.6) to specialized excitable membrane domains (axon ini-
tial segments and nodes of Ranvier) in Purkinje and granule cell 
neurons (  Zhou et al., 1998; Jenkins and Bennett, 2001  ;   Garrido 
et al., 2003  ;   Lemaillet et al., 2003  ). Mice lacking ankyrin-G ex-
pression in the cerebellum display a loss of Na  v   channel target-
ing, abnormal neuronal action potentials, and ataxia (  Zhou 
et al., 1998; Jenkins and Bennett, 2001  ). In 2003, two independent 
groups identifi  ed a small binding motif in the Na  v 1.2  DII – DIII 
cytoplasmic loop required for ankyrin-G association (  Garrido 
et al., 2003  ;   Lemaillet et al., 2003  ). 
  Our group recently identifi  ed 190-kD ankyrin-G expres-
sion in the heart (  Mohler et al., 2004b  ). Like Na  v  1.5, ankyrin-G is 
expressed at the intercalated disc and transverse tubules and 
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  Results 
  Generation of cardiomyocytes lacking 
ankyrin-G 
  We developed rat cardiomyocyte primary cultures with reduced 
ankyrin-G expression using lentiviral-mediated delivery of shRNA. 
The shRNA was designed to target all identifi  ed ankyrin-G 
mRNAs and was specifi  c for rodent ankyrin-G (versus human; 
  Fig. 1, A and B  ). We modifi  ed the lentiviral construct to encode 
YFP to enable the identifi  cation of transduced cells. A human-
specific ankyrin-G shRNA was generated for control experi-
ments (  Fig. 1 A  ). 
 Rodent-specifi  c ankyrin-G shRNA is effi  cient for reduc-
ing ankyrin-G expression and does not interfere with human 
ankyrin-G expression (  Fig. 1  ). Introduction of rodent-specifi  c 
ankyrin-G shRNA into primary rat cardiomyocytes signifi  cantly 
reduced ankyrin-G protein expression (  Fig. 1, C and D  ). Like-
wise, human-specifi  c ankyrin-G shRNA reduced ankyrin-G ex-
pression in human-derived HEK293 cells (  Fig. 1 C  ). Finally, no 
signifi  cant decrease in ankyrin-G levels was observed in rat cardio-
myocytes transduced with human-specific ankyrin-G shRNA 
(  Fig. 1 D  ). Equivalent viral expression was observed in each cell 
system (assessed by positive YFP fl  uorescence). 
  Ankyrin-G is required for normal Na  v  1.5 
expression and localization 
  Rat cardiomyocytes lacking a full complement of ankyrin-G 
expression were used to test the role of ankyrin-G for Na  v 1.5 
expression. As shown in   Fig. 1  , viral transduction of ankyrin-G 
associates with Na  v  1.5 in coimmunoprecipitation and in vitro 
binding experiments (  Mohler et al., 2004b  ). The nine  –  amino 
acid ankyrin-binding sequence identifi  ed in Na  v  1.2 (  Garrido et al., 
2003  ;   Lemaillet et al., 2003  ) is present in Na  v  1.5 and is required 
for Na  v  1.5  –  ankyrin-G interaction (  Mohler et al., 2004b  ). A hu-
man Brugada Syndrome   SCN5A   variant in the Nav1.5 ankyrin-G  –
  binding motif (E1053K) abolishes ankyrin-G  –  Na  v 1.5  interaction, 
and this Na  v   channel mutant is not effi  ciently targeted to cardio-
myocyte membranes (  Mohler et al., 2004b  ). Although largely 
circumstantial, these data support a potential role for an ankyrin-G –
  dependent pathway in Na  v  1.5 targeting to excitable membrane 
domains in the heart. 
  In this study, we report new data that conclusively links 
ankyrin-G activity and Na  v  1.5 membrane expression and local-
ization in cardiomyocytes. Using viral-mediated small hairpin 
RNA (shRNA) transfer into primary cardiomyocytes, we dem-
onstrate that a full complement of ankyrin-G expression is 
required for Na  v  1.5 expression and membrane localization. 
Specifi  cally, reduced ankyrin-G expression decreases (1) total 
cellular Na  v  1.5 expression, (2) effi  cient membrane localization, 
and (3) total Na 
+   membrane current. We also demonstrate that 
although ankyrin-G is required for normal Na  v 1.5  membrane 
expression, reduced ankyrin-G expression does not affect Na  v 1.5 
channel kinetics. Finally, we report the structural requirements 
for direct ankyrin-G  –  Na  v  1.5 interactions and show that direct 
intermolecular interaction between these two molecules is re-
quired for effi  cient channel membrane localization. Together, 
these data identify the fi  rst clear cellular pathway for Na  v   channel 
traffi  cking in the heart. 
  Figure 1.       Species-speciﬁ   c knockdown of 
190-kD ankyrin-G in rat myocytes using lenti-
viral shRNA.   (A) Domain organization of 190-kD 
ankyrin-G with the site of shRNA target. Rat, 
mouse, and human shRNA nucleotide target se-
quences. Note that the human 190-kD ankyrin-G 
target sequence has three unique nucleotides 
in wobble base positions (asterisks) that render 
this target sequence resistant to the rat shRNA. 
(B) The 21-nucleotide target sequence (sense) is 
separated by a short loop spacer sequence fol-
lowed by 21 nucleotides that form the reverse 
complement of the target sequence. (C) Rat 
and human species  –  speciﬁ  c  shRNAs  reduce 
190-kD ankyrin-G expression. Rat myocytes 
or human HEK293 cells were transduced with 
control virus, rat ankyrin-G shRNA, or human 
ankyrin-G shRNA. Equal quantities of protein 
were analyzed by immunoblotting using afﬁ  nity-
puriﬁ  ed ankyrin-G Ig or an antibody to an 
unrelated protein, NHERF1 (loading control). 
Note that the rat-speciﬁ   c ankyrin-G shRNA 
effectively reduces the expression of 190-kD 
ankyrin-G in rat cardiomyocytes. Moreover, the 
expression of 190-kD ankyrin-G is reduced in 
HEK293 cells transduced with human-speciﬁ  c 
ankyrin-G shRNA. (D) 190-kD ankyrin-G protein 
levels from whole cell lysates of rat cardiomyo-
cytes transduced with control virus, human-
speciﬁ  c ankyrin-G shRNA virus (hAnkG shRNA), 
or rat-speciﬁ   c ankyrin-G shRNA virus (rAnkG 
shRNA) were analyzed by immunoblotting and 
quantitated. Numbers represent the mean   ±   SD 
(error bars) from four independent experiments. 
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shRNA signifi  cantly reduces ankyrin-G expression (transduc-
tion effi  ciency of 80  –  95% based on YFP fl  uorescence  ; Fig. 2  ). 
Moreover, a striking reduction in Na  v  1.5 protein levels was ob-
served in the identical cell lysates from rat-specifi  c ankyrin-G 
shRNA virally transduced myocytes (  Fig. 2  ). This reduction was 
specifi  c to Na  v  1.5, as expression differences in cardiomyocyte 
membrane  –  associated proteins, including NHERF1, connexin43, 
ankyrin-B, Ca  v  1.2 (  Fig. 2  ), SERCA2, Na/K ATPase, or Na/Ca 
exchanger (not depicted), were not observed. 
  The role of ankyrin-G on single cardiomyocyte Na  v 1.5  ex-
pression was examined using immunofl  uorescence and confocal 
microscopy. In agreement with immunoblot data of cardiomyo-
cyte populations ( Fig. 2 ), reduced ankyrin-G expression resulted 
in a dramatic loss of Na  v  1.5 cellular expression (  Fig. 3 C  ) com-
pared with nontransduced ( Fig. 3 A ), YFP-transduced ( Fig. 3 B ), 
and human-specifi  c  ankyrin-G  shRNA  –  transduced  myocytes 
(  Fig. 3 D  ). Specifi  cally, Na  v  1.5 expression appeared to only 
remain in the perinuclear region of cardiomyocytes lacking 
ankyrin-G expression (  Fig. 3 C  ). Loss of protein localization was 
limited to Na  v  1.5, as cardiomyocytes transduced with ankyrin-G 
shRNA displayed no difference in the expression or localization 
of either Ca  v  1.2 or Na/Ca exchanger (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200710107/DC1). 
  Ankyrin-B is not required for Na  v  1.5 
expression in cardiomyocytes 
  Ankyrin-B (encoded by   ANK2  ) is required for the membrane tar-
geting of Na/Ca exchanger, InsP  3   receptor, and Na/K ATPase in 
cardiomyocytes (  Mohler et al., 2002, 2003, 2005  ). Ankyrin-B 
and -G are structurally similar and share binding activity for pro-
tein partners, including     -spectrin and Na/K ATPase (  Devarajan 
et al., 1994  ;   Kizhatil and Bennett, 2004  ;   Mohler et al., 2004d, 
2005; Kizhatil et al., 2007  ). We used primary cardiomyocytes 
from ankyrin-B  –  null mice to test whether ankyrin-B expression 
is necessary for Na  v 1.5 membrane expression. Confocal analyses 
of wild-type, ankyrin-B 
+/    ,  and  ankyrin-B – null  cardiomyocytes 
revealed no difference in Na  v  1.5 immunolocalization (  Fig. 4, 
A – C ). Therefore, even in myocytes completely devoid of ankyrin-B 
expression, Na  v  1.5 was normally expressed and properly local-
ized. These results demonstrate that ankyrin-G (not ankyrin-B) is 
the physiological binding partner for Na  v  1.5 in the heart. 
  Ankyrin-G is required for normal Na  v  1.5-
dependent Na 
+   current in cardiomyocytes 
  We made electrophysiological measurements to determine 
whether reduced ankyrin-G expression signifi  cantly affects Na  v  
channel membrane current density in primary cardiomyocytes 
(  Fig. 5  ). Wild-type rat cardiomyocytes and cardiomyocytes 
transduced with human- or rat-specifi  c ankyrin-G shRNA virus 
were analyzed for sodium current using whole-cell patch clamp 
(see  Fig. 5 D  [inset] for protocol). Virally transduced cardiomyo-
cytes were selected for electrophysiological measurements on 
the basis of positive YFP fl  uorescence. Cardiomyocytes infected 
with human-specifi  c ankyrin-G shRNA virus displayed no change 
in peak Na 
+   current compared with control (nontransduced) 
myocytes (note the current traces in   Fig. 5 [A and B  ] and the 
current-voltage relationship in   Fig. 5 D  ). In contrast, myocytes 
  Figure 2.       Na  v  1.5 expression is reduced in rat myocytes with reduced 
ankyrin-G expression.   Neonatal cardiomyocytes were transduced with 
rat-speciﬁ  c ankyrin-G shRNA virus. After 22 h, myocytes were collected, 
and whole cell lysates were generated. Equal protein concentrations were 
analyzed by immunoblot using afﬁ  nity-puriﬁ  ed ankyrin-G Ig and Na  v  1.5-
speciﬁ  c antibody. In parallel, blots were probed with an unrelated Ig to en-
sure equal protein loading (NHERF1). Note that loss of 190-kD ankyrin-G 
expression in myocytes transduced with rat-speciﬁ  c ankyrin-G shRNA 
was paralleled by a signiﬁ  cant reduction in Na  v  1.5 expression. Reduced 
ankyrin-G expression did not affect the expression of ankyrin-B, connexin43, 
or Ca  v  1.2. Molecular masses are expressed in kilodaltons.     JCB • VOLUME 180 • NUMBER 1 • 2008  176
transduced with rat-specifi  c ankyrin-G shRNA virus displayed 
striking decreases in peak Na 
+   current density (note the traces in 
  Fig. 5 C  ; currents normalized for cell capacitance). In fact, several 
transduced cells that completely lacked detectable Na 
+   current 
(data not included in statistical analyses for   Figs. 5   and 6; see 
Materials and methods) were observed. These functional data 
strongly support a role for ankyrin-G in Na  v  1.5 membrane surface 
targeting in cardiomyocytes. 
  Figure 3.       Na  v  1.5 expression is reduced in single rat myocytes with reduced ankyrin-G expression.   (A  –  D) Control myocytes (uninfected; A) and cardiomyo-
cytes transduced with control virus (YFP alone; B), rat-speciﬁ  c ankyrin-G shRNA virus (C), or human-speciﬁ  c ankyrin-G shRNA virus (D) were immunolabeled 
with ankyrin-G and Na  v  1.5-speciﬁ  c antibodies and imaged using identical confocal settings. Viral transduction was assessed by the presence of YFP ﬂ  uor-
escence (pseudocolored in blue in B  –  D for clarity). Note that only myocytes infected with rat-speciﬁ  c ankyrin-G shRNA virus displayed reduced ankyrin-G 
expression. These myocytes consistently displayed a decreased expression of Na  v  1.5. In fact, Na  v  1.5 expression in myocytes with reduced ankyrin-G 
expression (arrowheads in C) was limited to the perinuclear region (arrows in C). Bars, 10     m.     
  To determine the specifi  city of the ankyrin-G  –  based cellular 
pathway for ion channel membrane targeting in cardiomyocytes, 
we evaluated the effect of reduced ankyrin-G expression on a sec-
ond critical cardiomyocyte membrane current. Ca  v 1.2-dependent 
calcium current (I  Ca ) is required for normal cardiac excitability, and 
human Ca  v 1.2 gene variants are associated with ventricular arrhyth-
mia ( Splawski et al., 2004 ). As expected, myocytes with reduced 
ankyrin-G expression displayed signifi  cant reduction in peak Na 
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observed in wild-type cardiomyocytes versus cardiomyocytes 
with reduced ankyrin-G expression (  Fig. 6  ). These data dem-
onstrate that in the physiological context of a cardiomyocyte, 
normal Na  v   channel inactivation does not require ankyrin-G. 
Surprisingly, inactivation of wild-type cardiomyocyte Na  v 1.5 
is independent of physiological localization. Thus, localization 
controls current density but not Na  v 1.5  inactivation.  These  data 
strongly demonstrate the critical nature of studying ankyrin 
  biology in the appropriate physiological context. 
  Direct interaction between ankyrin-G and 
Na  v  1.5 requires ANK repeat 14  –  15 
    -hairpin loop tips 
 We identifi  ed the structural requirements on ankyrin-G for di-
rect Na  v  1.5 interaction using a series of ankyrin-G   ANK   repeat 
mutants (  Fig. 7, A  –  C  ). These mutants were created based on 
the identifi  cation of exposed, highly accessible residues on the 
    -hairpin loop tips of the ankyrin-R membrane  –  binding domain 
(repeats 13  –  24) crystal structure (  Michaely et al., 2002  ) as well as 
the identifi  cation of membrane  –  protein binding sites at these 
sites in ankyrin-B (  Mohler et al., 2004a; Cunha et al., 2007  ). 
Specifi  cally, each of the 24 consecutive   ANK   repeats of an ankyrin 
membrane  –  binding domain fold as antiparallel pairs of      helices 
connected by a     -hairpin loop. The large number of consecutive 
  ANK   repeats come together to form a super helix that surrounds a 
large central cavity (  Michaely et al., 2002  ). Thus, these variable 
    -hairpin loops are highly accessible to the solvent for potential 
protein interactions ( Fig. 7 C ). This strategy has been successfully 
used to map the binding sites on ankyrin-B for Na/Ca exchanger 
and InsP  3   receptor (  Mohler et al., 2004a; Cunha et al., 2007  ). 
current amplitude (  Fig. 5, F and G  ). However, these identical myo-
cytes displayed peak calcium current (I  Ca ) measurements that were 
unchanged from those observed in control (nontransduced) or 
human-specifi  c ankyrin-G shRNA virally transduced cardiomyo-
cytes (see Materials and methods for protocol details  ; Fig. 5, 
F and G  ). These data (combined with Na  v 1.5/Ca v 1.2  immuno blot 
and immunostaining data in   Figs. 2  –  4   and S1) establish that the 
cardiac ankyrin-G  –  targeting pathway is specifi  c for Na  v 1.5  chan-
nels and that loss of Na  v  1.5 membrane expression in ankyrin-G  –
 defi  cient cells is not simply the result of the general impairment of 
default myocyte membrane biogenesis/traffi  cking pathways. 
  Na  v  1.5 channel inactivation is unaffected 
in cardiomyocytes with reduced ankyrin-G 
expression 
 Human Na v 1.5 Brugada Syndrome variant E1053K, which lacks 
ankyrin-G  –  binding activity, is not effi  ciently targeted to the car-
diomyocyte intercalated disc (  Mohler et al., 2004b  ). However, 
when introduced into heterologous HEK293 cells, this mutant 
channel is present at the plasma membrane but displays abnor-
malities in Na  v  1.5 inactivation (  Mohler et al., 2004b  ). Further-
more, similar data examining Na  v  1.2 biophysical properties in 
TsA201 cells support the concept that ankyrin-G could poten-
tially regulate the biophysical properties of Na  v   channels in het-
erologous cells (  Shirahata et al., 2006  ). These studies did not 
determine whether the inactivation of wild-type Na  v 1.5 channels 
requires correct localization through ankyrin-G. Therefore, we 
tested whether primary cardiomyocytes with reduced ankyrin-G 
expression displayed abnormalities in Na  v   channel  inactivation. 
No signifi  cant difference in Na  v  1.5 channel inactivation was 
  Figure 4.       Na  v  1.5 is normally expressed in cardio-
myocytes with reduced ankyrin-B expression.   Immuno-
localization of ankyrin-B and Na  v  1.5 in neonatal 
myocytes derived from wild-type (A), ankyrin-B 
+/      (B), 
and ankyrin-B 
    /      mice (C). Note that although ankyrin-B 
levels are reduced     50% in ankyrin-B 
+/      myocytes 
and nearly 100% in ankyrin-B 
    /      cardiomyocytes, 
there is no reduction in Na  v  1.5 expression/localization. 
Bars, 10     m.     JCB • VOLUME 180 • NUMBER 1 • 2008  178
each pair of   ANK   repeats within the membrane-binding domain 
(  ANK   repeats 1  –  24;   Fig. 7, B and C  ). Mutagenesis was performed 
in the context of GFP-tagged ankyrin-G (  Mohler et al., 2002  ). 
  24 individual ankyrin-G   ANK   repeat mutants were gener-
ated for binding analyses. Each ankyrin-G mutant harbored two 
alanine substitutions in the variable     -hairpin loop tips connecting 
  Figure 5.       Reduced sodium current amplitude and current-voltage kinetics in myocytes with reduced ankyrin-G expression.   Nontransduced cardiomyocytes 
(control) and cardiomyocytes transduced with human- (hAnkG) or rat-speciﬁ  c (rAnkG) shRNA virus were analyzed for Na  v  1.5 current. (A  –  C) Whole-cell 
patch clamp sodium current traces elicited control (A; 17 pF), human ankyrin-G  –  speciﬁ  c shRNA  –  transduced cells (B; 18 pF), and rat-speciﬁ  c ankyrin-G 
shRNA  –  transduced cells (C; 16.8 pF). All cardiomyocytes displayed similar cell capacitance, and all traces are normalized for cell capacitance. (D) Mean 
and normalized current-voltage relationship for neonatal rat ventricular cardiomyocytes treated with control virus (black squares;   n   = 10), human ankyrin-G 
shRNA virus (gray circles;   n   = 10), and rat ankyrin-G shRNA virus (white squares;   n   = 10). (E) Normalized maximum sodium current amplitude in myocytes 
treated with control (black bar) and rat- (white bar) and human (gray bar)-speciﬁ  c ankyrin-G shRNA virus. *, P   <   0.05. (F and G) Reduced ankyrin-G ex-
pression speciﬁ  cally affects cardiomyocyte sodium current. (F) Amplitude of Na 
+   and Ca 
2+   current in nontransduced (control) and rat neonatal cardiomyo-
cytes transduced with ankyrin-G species-speciﬁ  c shRNA viruses. Currents are elicited with the protocol shown in the inset (see Materials and methods for 
details). Left panels depict Na 
+   and Ca 
2+   current in cardiomyocytes treated with control or human ankyrin-G  –  speciﬁ  c shRNA virus (hAnkG shRNA). Right 
panels display the signiﬁ  cant decrease in I  Na  , but not I  Ca  , in cardiomyocytes transduced with rat-speciﬁ  c ankyrin-G shRNA virus (rAnkG shRNA). All traces 
are normalized for cell capacitance. (G) Reduced ankyrin-G expression leads to reduced I  Na   but does not affect cardiomyocyte I  Ca  . (E and G) Data are 
plotted as mean   ±   SEM (error bars;   n   = 10). Statistical difference was analyzed by analysis of variance.     179 ANKYRIN-G TARGETS NA    V    1.5 IN THE HEART   •   LOWE ET AL.
Mutant plasmids were completely sequenced to verify that no 
additional mutations were introduced during PCR amplifi  cation. 
Wild-type ankyrin-G and each GFP ankyrin-G mutant were ex-
pressed in HEK293 cells. Expressed proteins were immuno-
purified from the detergent-soluble fraction of the cells using 
immobilized affi  nity-purifi  ed GFP Ig and were incubated with 
purifi  ed His-tagged Na  v  1.5 DII  –  DIII cytoplasmic loop (site 
for ankyrin-G association on Na  v  1.5;   Mohler et al., 2004b  ). 
The quantity of pure Na  v  1.5 DII  –  DIII bound to each mutant was 
determined by immunoblotting using a His tag Ig. Using similar 
methods, the relative level of GFP – ankyrin-G mutant expression for 
each data point was determined. The amount of Na  v 1.5 His-tagged 
DII  –  DIII bound to each ankyrin-G mutant was corrected for rela-
tive GFP  –  ankyrin-G expression in each experimental sample. 
  Although the majority of ankyrin-G mutants associated 
with Na  v  1.5 His-tagged DII  –  DIII at levels similar to wild-type 
GFP  –  ankyrin-G, there was a signifi  cant reduction in DII  –  DIII 
binding to ankyrin-G mutants R13, R14, and R15 (  Fig. 7, D and 
E  ). In fact, GFP  –  ankyrin-G mutants R14 and R15 displayed a 
near complete loss of Na  v  1.5 DII  –  DIII binding activity in these 
assays. Together, our fi   ndings demonstrate that ankyrin-G  –
  Nav1.5 binding is exclusively dependent on three critical ele-
ments (two     -hairpin loops on ankyrin-G and a nine  –  amino 
acid motif on Na  v  1.5;   Mohler et al., 2004b  ). 
  Human ankyrin-G expression rescues 
abnormal Nav1.5 localization 
 We performed rescue assays to determine whether the loss of Na  v 1.5 
localization in cardiomyocytes with reduced ankyrin-G ex  pression 
was specifi  cally caused by the monogenic loss of ankyrin-G. Rat 
neonatal cardiomyocytes with reduced levels of ankyrin-G and 
Na  v  1.5 (as a result of the presence of rat-specifi  c ankyrin-G 
shRNA virus) were transfected with cDNA encoding human 
GFP  –  ankyrin-G. This GFP  –  ankyrin-G cDNA is resistant to the 
rat ankyrin-G shRNA (  Fig. 1  ). As expected, shRNA-transduced 
cardiomyocytes displayed decreased expression and abnormal 
localization of Na  v 1.5 ( Fig. 8 B ). In contrast, shRNA-transduced 
cardiomyocytes expressing human GFP  –  ankyrin-G cDNA dis-
played a Na  v  1.5 distribution similar to wild-type cardiomyo-
cytes (  Fig. 8 C  ). These data demonstrate that abnormal Na  v 1.5 
localization in ankyrin-G  –  null cardiomyocytes can be rescued 
by the exogenous expression of human ankyrin-G and reinforce 
the critical role for ankyrin-G in the subcellular localization of 
Na  v  1.5 in cardiomyocytes. 
  Direct ankyrin-G  –  Na  v  1.5 interaction is 
required for Na  v  1.5 localization 
  We used the aforementioned ankyrin-G rescue assay with 
ankyrin-G mutants that lack Na  v  1.5-binding activity (  Fig. 7  ) to 
determine whether direct ankyrin-G  –  Na  v  1.5 interactions are 
  required for Na  v  1.5 localization in cardiomyocytes. Ankyrin-G 
mutants lacking Na  v  1.5-binding activity were introduced into 
full-length human GFP  –  ankyrin-G cDNA to create human 
GFP  –  ankyrin-G R14 and R15 (both resistant to rat ankyrin-G 
shRNA). Cardiomyocytes with reduced ankyrin-G expression 
(transduced with rat ankyrin-G YFP virus) were transfected 
with human GFP  –  ankyrin-G or human ankyrin-G R14 or R15 
mutant cDNAs. YFP-positive cardiomyocytes (express shRNA) 
were fixed and immunostained. GFP  –  ankyrin-G is properly 
targeted in neonatal cardiomyocytes and rescues the normal 
expression of Na  v  1.5 (  Fig. 8 C  ). In contrast, although both 
GFP  –  ankyrin-G R14 and GFP  –  ankyrin-G R15 were properly 
localized in transfected cardiomyocytes, there was no detect-
able rescue of Na  v  1.5 localization as observed with wild-type 
human GFP  –  ankyrin-G (  Fig. 8 C  ). In fact, the localization of 
Na  v  1.5 in myocytes transfected with GFP  –  ankyrin-G R14  –  15 
was similar to nontransfected myocytes lacking endogenous 
ankyrin-G expression (  Fig. 8, B, D, and E  ). Therefore, direct asso-
ciation of ankyrin-G with Na  v  1.5 is required for the membrane 
expression of Na  v  1.5 in ventricular cardiomyocytes. 
  Figure 6.       Reduced ankyrin-G expression does not affect Na  v  1.5 inactivation in primary cardiomyocytes.   Superimposed Na  v  1.5 inactivation curves 
obtained from neonatal rat cardiomyocytes treated with control (black squares) and species-speciﬁ  c (human, gray circles; rat, white squares) ankyrin-G 
shRNA viruses. The normalized I  Na   plotted against preconditioning pulse potential was ﬁ  tted using a Boltzmann equation. Voltage-dependent steady-state 
inactivation was determined using a paired two-pulse protocol. Each conditioning voltage is paired with a control after 1.5 s. A 500-ms conditioning pulse 
from     120 to 20 mV in 10-mV increments was followed by a test pulse to     30 mV. The test pulse in each series is separated from the conditioning pulse 
by a 2-ms interval to     120 mV. Each point (I  Na  ) is normalized against the amplitude of corresponding control pulse (I  Namax  ). Each point represents mean   ±   
SEM (error bars;   n   = 5).     JCB • VOLUME 180 • NUMBER 1 • 2008  180
strate that direct interaction of the ankyrin-G membrane  –  binding 
domain and Na  v 1.5 DII – DIII loop is necessary for Na  v 1.5 expres-
sion and localization at the cardiomyocyte membrane surface. 
Our new data provide compelling evidence that ankyrin-G  –
  dependent targeting of Na  v  1.5 is a fundamental requirement for 
cardiomyocytes and likely other excitable cells. 
  Ankyrin polypeptides have likely coordinately evolved 
to regulate electrical activity in the heart by targeting key ion 
channels/transporters involved in controlling the cardiac action 
potential. Ankyrin-G directly associates with and targets Na  v 1.5 
to the membrane surface (  Fig. 9 A  ) to regulate inward Na 
+  
current and, thus, action potential initiation and cardiomyocyte 
depolarization. Therefore, it is not surprising that human  SCN5A  
variants that disrupt ankyrin-G interactions are associated with 
the Brugada Syndrome ( Priori et al., 2002; Mohler et al., 2004b ), 
a cardiac syndrome associated with reduced inward I  Na   (for  re-
view see   Napolitano and Priori, 2006  ). Clinical features of the 
Brugada Syndrome include fast polymorphic ventricular tachy-
cardia typically occurring at rest or during sleep (  Wilde and 
Priori, 2000 ). In contrast, ankyrin-B targets distinct ion channels 
and transporters with central roles in cytosolic calcium extru-
sion during cardiac repolarization (  Mohler et al., 2002, 2003, 
2004c, 2005, 2007  ;   Cunha et al., 2007  ). Ankyrin-B (product 
of the   ANK2   gene) is required for targeting Na/Ca exchanger, 
Na/K ATPase, and InsP  3   receptor to the transverse tubule and 
  Ankyrin-G is required for normal Na  v  1.5 
expression in adult cardiomyocytes 
  To test whether our fi  ndings in neonatal myocytes can also be ap-
plied to adult cardiomyocytes, we performed ankyrin-G shRNA 
viral transduction of freshly isolated adult rat cardiomyocytes. 
Na  v  1.5 expression is most pronounced at the intercalated disc of 
adult cardiomyocytes (see Na  v  1.5 localization in the control 
myocyte; Fig. S2 A, available at http://www.jcb.org/cgi/content/
full/jcb.200710107/DC1). Therefore, we tested whether ankyrin-G 
expression is required for Na  v  1.5 localization at the mature 
cardiomyocyte intercalated disc. Reduced ankyrin-G expression 
in adult myocytes results in the reduced membrane expression of 
Na  v  1.5 (note the loss of Na  v  1.5 intercalated disc staining in Fig. 
S2 B), which is consistent with results in neonatal cardiomyo-
cytes. In fact, identical with our fi  ndings in neonatal cells, we 
observed that Na  v  1.5 localized to the perinuclear region (Fig. S2 B) 
in adult cardiomyocytes with reduced ankyrin-G expression. 
These data from isolated adult cardiomyocytes further confi  rm 
the role of the ankyrin-G  –  based protein-targeting pathway for 
Na  v  1.5 membrane expression in the heart. 
  Discussion 
  In this study, we present the fi  rst report of a cellular pathway 
required for Na  v  channel traffi  cking in cardiomyocytes. We demon-
  Figure 7.       Direct interaction of ankyrin-G with 
Na  v  1.5 requires two ANK repeat     -hairpin 
loop tips on the ankyrin-G membrane  –  bind-
ing domain.   (A) 190-kD ankyrin-G includes 
a membrane-binding domain comprised of 
24 consecutive   ANK   repeats (green), a spec-
trin-binding domain (black), a death domain 
(blue), and a C-terminal domain (red). (B)   ANK   
repeat mutants were engineered in the context 
of full-length GFP 190-kD ankyrin-G and dis-
play alanine substitutions for the two residues 
located at the tip of each   ANK   repeat     -hairpin 
loop (red arrowheads in B and purple sites 
in C). (C) Crystal structure diagram of mem-
brane-binding domain   ANK   repeats 13  –  24 
(  Michaely et al., 2002  ). Exposed charged res-
idues on     -hairpin loop tips (sites of alanine 
mutagenesis) are colored in purple. (D) Rela-
tive binding (compared with wild-type GFP 
190-kD ankyrin-G) of GFP 190-kD ankyrin-G 
  ANK   repeat mutants with puriﬁ  ed Na  v  1.5 DII  –
  DIII cytoplasmic domain (  n   = 3; *, P   <   0.05). 
Binding levels are corrected for the relative ex-
pression of each GFP  –  ankyrin-G mutant. Error 
bars represent SEM. (E) Na  v  1.5 binding sites 
(arrows) superimposed on the deduced crys-
tal structure of the ankyrin-G membrane  –  bind-
ing domain (  ANK   repeats 13  –  24). Ankyrin-G 
membrane  –  binding domain structure is based 
on the crystal structure of   ANK   repeats 13  –  24 
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ankyrin-B for both integral membrane and signaling proteins in 
the heart suggests that the ankyrin-G  –  targeting pathway may 
similarly facilitate the localization of additional myocyte pro-
teins. Moreover, our new fi  ndings for ankyrin-G in Na  v 1.5  tar-
geting identify an attractive, unconventional candidate disease 
gene for cardiac (arrhythmia and myopathy) and other excitable 
cell diseases. 
  Based on the role of ankyrin-R in the erythrocyte (  Bennett 
and Stenbuck, 1979  ), cardiac ankyrin-G may simply act as a 
membrane scaffold to link integral membrane proteins (such as 
Na  v  1.5) with the underlying actin- and spectrin-based cytoskel-
eton. In support of this role, we observe a signifi  cant level of 
Na  v  1.5 clustering on the plasma membrane surface with ankyrin-G 
as assessed by immunoelectron microscopy of cardiomyocyte 
membrane sheets (  Fig. 10  ). Alternatively, ankyrin-G may play 
an active role in the cellular traffi  cking of Na  v  1.5 to specifi  c 
membrane domains. In theory, ankyrin-G could have multiple 
  sarcoplasmic reticulum in cardiomyocytes (  Fig. 9 B  ;   Mohler 
et al., 2003, 2005  ). 
  Dysfunction in ankyrin-B  –  based cellular pathways as a 
result of human   ANK2   variants are associated with ankyrin-B 
syndrome, a cardiac arrhythmia with a host of phenotypes, in-
cluding sinoatrial node dysfunction, atrial fi  brillation, conduc-
tion defects, and ventricular tachycardia and/or sudden cardiac 
death (  Mohler et al., 2003, 2004c, 2007  ). In contrast to Na  v 1.5-
associated Brugada Syndrome, ventricular tachycardia and 
syncopal events in the ankyrin-B syndrome are most often asso-
ciated with adrenergic stimulation (e.g., emotional stress and/or 
exercise, similar to catecholaminergic polymorphic arrhythmia; 
  Mohler et al., 2003, 2004c, 2007  ;   Liu et al., 2007  ). 
  In addition to targeting ion channels in cardiomyocytes, 
ankyrin-B was recently shown to be required for targeting of the 
regulatory subunit of the PP2A complex in primary cardiomyo-
cytes (  Fig. 9 B  ;   Bhasin et al., 2007  ). This broad targeting role of 
  Figure 8.       Na  v  1.5 targeting requires direct 
interaction with 190-kD ankyrin-G.   (A and B) 
Immunolocalization of ankyrin-G and Na  v  1.5 
in control (nontransduced) and rat ankyrin-G 
shRNA virally transduced neonatal cardiomyo-
cytes. Note the localization of Na  v  1.5 in the 
perinuclear region of shRNA-transduced myo-
cytes (white arrows). Yellow arrows denote 
remaining ankyrin-G staining in transduced 
myocytes, and asterisks mark sites of complete 
knockdown. Virally transduced myocytes in the 
ﬁ  gure are denoted by positive YFP ﬂ  uorescence 
(pseudocolored in blue). (C) Cardiomyocytes 
expressing rat-speciﬁ  c ankyrin-G shRNA (note 
the blue color denoting YFP expression) were 
transfected with GFP-labeled human ankyrin-G 
cDNA and immunolabeled with Na  v  1.5 and 
ankyrin-G antibodies. Note that human GFP  –
  ankyrin-G restores the localization of Na  v  1.5 
to normal (compare Na  v  1.5 in B and C). 
(D and E) GFP-human ankyrin-G mutants (R14 
and R15) that lack binding activity for Na  v  1.5 
(see   Fig. 6  ) are unable to rescue to normal the 
aberrant localization of Na  v  1.5 (note peri-
nuclear distribution; arrows) in myocytes stably 
transduced with rat ankyrin-G shRNA (note 
positive YFP ﬂ  uorescence). Bars, 10     m.     JCB • VOLUME 180 • NUMBER 1 • 2008  182
These fi  ndings are in contrast to a recent publication that demon-
strated abnormal inactivation gating of Na  v  1.2 in TsA201 cells 
(modifi  ed HEK293 cell) lacking ankyrin-G (  Shirahata et al., 
2006  ). Our new data suggest that these measurements should be 
reevaluated in the context of a neuron. 
  The critical role of ion channels and transporters for nor-
mal cardiac function has been highlighted by the linkage of 
gene mutations in cardiac ion channels and associated subunits 
with human arrhythmia (  Lehnart et al., 2007  ). Specifi  cally, hu-
man gene variants in   KCNQ1   (KvLQT1),   KCNH2   (HERG), 
  SCN5A   (Nav1.5),   KCNE1   (minK),   KCNE2   (MiRP),   KCNJ2  
(Kir2.1), and   CACNA1C   (Cav1.2) have been associated with 
potentially fatal long QT arrhythmias (  Lehnart et al., 2007  ). 
Most channel variants affect channel biophysics (  Lehnart et al., 
2007  ). However, recent fi  ndings suggest that dysfunction in 
channel traffi  cking mechanisms may explain a signifi  cant num-
ber of long QT variant cellular phenotypes (  Zhou et al., 1999; 
Mohler et al., 2003 ;  Ye et al., 2003 ;  Gouas et al., 2004 ;  Krumerman 
et al., 2004  ;   Liu et al., 2005  ;   Anderson et al., 2006  ;   Ballester et al., 
2006; Schmitt et al., 2007  ). 
  Cardiomyocytes have clearly evolved unique channel 
traffi  cking pathways for the precise localization of specifi  c ion 
channels to unique cardiomyocyte membrane domains. For 
example, although Na  v 1.5,  K v  4.2, and connexin 43 are concen-
trated at the intercalated disc (  Kanter et al., 1992  ;   Barry et al., 
1995  ;   Maier et al., 2002  ;   Mohler et al., 2004b  ), Kir2.1, Kir2.3, 
and Ca  v  1.2 are primarily localized to transverse tubule mem-
branes (  Carl et al., 1995  ;   Sun et al., 1995;     Clark et al., 2001  ; 
  Melnyk et al., 2002  ). Moreover, signifi  cant populations of Kv-
LQT1, ERG, minK, MiRP, Na/Ca exchanger, and Na/K ATPase 
are found at transverse tubule and peripheral sarcolemma mem-
branes (  Frank et al., 1992  ;   Kieval et al., 1992  ;   McDonough et al., 
1996  ;   Pond et al., 2000  ;   Rasmussen et al., 2004  ;   Wu et al., 2006  ). 
Finally, high resolution imaging techniques have revealed unique 
roles in both traffi  cking and stabilization/retention of Na  v 1.5 
channels in the heart. Although these fi  ndings are beyond the 
scope of this study, elucidating the specifi  c cellular roles of an-
kyrin polypeptides in excitable cells is an obvious future goal 
for the fi  eld. 
  Reduction of ankyrin-G in cardiomyocytes signifi  cantly 
affects the expression (  >  75%;   Fig. 2  ) and cellular localization 
of Na  v  1.5 (  Fig. 3  ). Although functional experiments on ankyrin-G 
shRNA myocytes reveal a striking reduction in I  Na   (50 – 65% 
reduction), residual I  Na  current was observed in these cells ( Fig. 5 ). 
This current may represent residual Na  v 1.5  activity.  Alterna-
tively, this remaining current may refl  ect the combined activity 
of other Na  v   isoforms (  Rogart et al., 1989; Baruscotti et al., 
1997  ;   Dhar Malhotra et al., 2001  ;   Maier et al., 2002, 2003, 
2004  ;   Haufe et al., 2005  ). In theory, these Na  v   channel isoforms 
may be targeted to the membrane via an ankyrin-G  –  independent 
cellular pathway and, therefore, may be resistant to ankyrin-G 
knockdown. These interesting data form the foundation for fu-
ture experiments to dissect the specificity of the ankyrin-G  –
  based cellular pathway for Na  v   channel isoform traffi  cking in 
the heart. 
  Our electrophysiological measurements illustrate the im-
portance of studying ankyrin  –  membrane protein interactions in 
the physiological context of a native cell. Our previous work 
suggested that Na  v  1.5 E1053K lacking ankyrin-G  –  binding ac-
tivity displayed minor yet signifi  cant abnormalities in activation 
and inactivation when expressed in HEK293 cells (  Mohler 
et al., 2004b  ). However, when expressed in native cardiomyocytes, 
these biophysical abnormalities were inconsequential, as the 
majority of the channel lacked suffi  cient targeting information 
to even reach the plasma membrane (  Mohler et al., 2004b  ). Our 
new fi  ndings demonstrate that in myocytes lacking ankyrin-G, the 
small number of residual Na  v  1.5 channels that reach the plasma 
membrane have effectively normal biophysical characteristics. 
  Figure 9.       Ankyrin-G and ankyrin-B ion 
channel/transporter complexes in the heart. 
  (A) Ankyrin-G is required for the targeting 
of Na  v  1.5 to the cardiomyocyte intercalated 
disc. Although other Na  v  1.5-interacting pro-
teins have been identiﬁ  ed, it is not yet clear 
whether these are present in the ankyrin-G  –
  dependent protein complex. (B) Ankyrin-B is re-
quired for the targeting of Na/Ca exchanger 
and Na/K ATPase to transverse tubule mem-
branes in the heart. InsP  3   receptor targeting to 
the sarcoplasmic reticulum membrane requires 
direct interaction with ankyrin-B. Cardiac an-
kyrin-B protein partners also include PP2A and 
    2-spectrin.     183 ANKYRIN-G TARGETS NA    V    1.5 IN THE HEART   •   LOWE ET AL.
fi  rst component of a larger ankyrin-G macromolecular signaling 
complex at cardiomyocyte excitable membrane domains. 
  Materials and methods 
  shRNA targets/cDNA constructs 
  Ankyrin-G  –  speciﬁ  c shRNA targets were selected based on their unique se-
quence presence of ﬂ  anking 5     AA and 3     TT nucleotides (  Brummelkamp 
et al., 2002  ). Human- and rat-speciﬁ  c targets were conferred by three unique 
nucleotides located at wobble positions. Primers were created and ligated 
into a modiﬁ  ed pFIV lentiviral vector (System Biosciences, Inc.). The vector 
was modiﬁ  ed to contain YFP driven by an independent H1PGK promoter to 
track transduced cells. Feline immunodeﬁ  ciency viruses were titered before 
transduction experiments. Ankyrin-G constructs were generated using 
190-kD ankyrin-G cDNA. GFP 190-kD ankyrin-G mutant constructs were 
made using QuikChange Mutagenesis (Stratagene). Loop mutations were 
designed to replace   ANK   repeat     -hairpin loop tip residues with two 
alanines. Rescue constructs were made using GFP 190-kD ankyrin-G and 
  ANK   repeat mutants R14 and R15. All constructs were completely sequenced 
and conﬁ  rmed to express protein in HEK293 cells. 
  Immunoblots 
  After viral and/or rescue treatment, cells were collected into PBS, pH 7.4. 
Cells were lysed using radioimmunoprecipitation assay buffer containing 
protease inhibitor cocktail. Detergent-soluble fractions were collected after 
high speed centrifugation, and protein concentrations were determined us-
ing a bicinchoninic acid protein assay kit (Thermo Fisher Scientiﬁ  c). Equal 
quantities of protein (20   μ  g) were analyzed by SDS-PAGE and immuno-
blotting. Equal loading was assessed by transfer to Ponceau S and blotting 
with NHERF1. 
  Neonatal rat cardiomyocytes 
  Hearts were dissected from postnatal day 1 rats and cultured as described 
previously (  Bhasin et al., 2007  ). 
  Adult cardiomyocytes 
  Myocytes were isolated from 250  –  300 g of Sprague-Dawley rats (  Grueter 
et al., 2006  ). Acutely isolated cardiomyocytes were then plated at high den-
sity (    2   ×   10 
6   per well), infected with rat-speciﬁ  c ankyrin-G shRNA virus or 
control virus for 9 h, and maintained for 22 h at 37  °  C before experiments. 
  Binding experiments 
  GFP 190-kD ankyrin-G and mutants were expressed in HEK293 cells 
and purified using affinity-purified GFP Ig coupled to protein A aga-
rose beads. Cells were lysed in homogenization buffer plus 1.0% Triton 
X-100 and 0.5% deoxycholate (  Mohler et al., 2005  ). The extract was 
transverse tubule membrane domains that further segregate 
cardiac ion channel signaling complexes (  Scriven et al., 2000  ). 
Clearly, the molecular and structural characteristics of cardiac 
membrane domains represent a central feature for the regulation 
of local ion channel pathways and represent a relatively un-
explored fi  eld in cell biology. 
  Ankyrin-based ion channel traffi  cking pathways have 
unique roles in specifi  c cells. Recently,   Pan et al.   (  2006  ) dem-
onstrated the requirement of ankyrin-G association for the 
targeting of KCNQ2 and KCNQ3 (encode axonal M currents 
responsible for stabilizing neuronal resting potential) to axon 
initial segments. Specifically, ankyrin-G cerebellar-specific 
null mice display loss of KCNQ2/3 clustering at axonal initial 
segments (  Pan et al., 2006  ). Moreover, the ankyrin-G  –  binding 
motif originally described in Na  v  1.2 and Na  v  1.5 (  Garrido et al., 
2003  ;   Lemaillet et al., 2003  ;   Mohler et al., 2004b  ) is present in 
the C-terminal domain of KCNQ2/3 and is required for neuro-
nal KCNQ2/3 targeting (  Chung et al., 2006  ;   Pan et al., 2006  ; 
  Rasmussen et al., 2007  ). Interestingly, although nearly structur-
ally identical, KCNQ1 (cardiac KvLQT1) lacks the C-terminal 
ankyrin-G  –  binding motif (  Pan et al., 2006  ). Consistent with this 
data, ankyrin-G and KCNQ1 are differentially targeted in ven-
tricular cardiomyocytes (  Mohler et al., 2004b  ;   Rasmussen et al., 
2004  ). Therefore, these data strongly suggest that ankyrin-based 
pathways operate in a cell type  –  specifi  c manner. 
  In summary, our new findings show that ankyrin-G is 
the physiological binding partner for Na  v  1.5 in cardiomyocytes. 
Loss of direct interaction between ankyrin-G and Na  v 1.5  results 
in abnormal Na  v  1.5 channel localization in primary cardiomyo-
cytes. Moreover, the loss of ankyrin-G expression affects Na  v 1.5 
expression, membrane localization, and, therefore, whole cell 
Na  v  1.5 activity. Based on recent ankyrin fi  ndings in the brain 
(  Dubreuil, 2006  ;   Pan et al., 2006  ;   Yang et al., 2007  ), heart 
(  Lencesova et al., 2004  ;   Mohler and Bennett, 2005a  ), and skele-
tal muscle (  Bagnato et al., 2003  ;   Kontrogianni-Konstantopoulos 
et al., 2004, 2006  ), our new fi  ndings likely represent only the 
  Figure 10.       Na  v  1.5 is clustered at the cardio-
myocyte membrane surface with ankyrin-G.   
Immunogold electron microscopy of adult rat 
ventricular cardiomyocyte plasma membrane 
sheets. Anti  –  ankyrin-G Ig particles (10 nm 
gold) and anti-Na  v  1.5 Ig particles (5 nm gold; 
arrows) are found in clusters at the plasma 
membrane. The majority of Na  v  1.5-positive 
gold particles were clustered in proximity 
(  <  10 nm) to ankyrin-G  –  positive gold particles 
(see A, B, and     D  –  F). However, we also observed 
a small fraction of Na  v  1.5-positive particles that 
were physically isolated from ankyrin-G (C). 
Membrane sheets labeled with gold-conjugated 
secondary antibodies (negative control) 
were clear of any gold particles (not depicted). 
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compensated value. The whole-cell bath solution contained 10 mM NaCl, 
130 mM choline chloride, 4.5 mM KCl, 1.8 mM CaCl  2  , 2.0 mM MgCl  2  , 
10.0 mM Hepes, and 5.5 mM glucose, pH 7.35, titrated with KOH. 
The pipette solution contained 130 mM CsCl, 0.5 mM CaCl  2  , 2 mM 
MgCl  2  , 5 mM Na  2  ATP, 0.5 mM GTP, 5 mM EGTA, and 10 mM Hepes, 
pH 7.3, titrated with CsOH. All electrophysiology experiments were per-
formed at room temperature (21  –  23  °  C). 
  Whole-cell voltage clamp Na 
+   current data were elicited from a 
holding potential of     120 mV to membrane potentials ranging from     110 
to 30 mV in the presence of 2.0 mM CoCl  2  . Voltage-dependent steady-
state inactivation was determined using a paired two-pulse protocol. Each 
conditioning voltage was paired with a control after 1.5 s. A 500-ms con-
ditioning pulse from     120 to 20 mV in 10-mV increments was followed by 
a test pulse to     30 mV. The test pulse in each series was separated form 
the conditioning pulse by a 2-ms interval to     120 mV. The steady-state in-
activation curves were constructed by normalizing currents to the maximal 
Na 
+   current elicited from a holding potential of     120 to     30 mV for a du-
ration of 20 ms. The resulting curve was ﬁ  tted using a Boltzmann distribu-
tion equation of the form I  Na   = I  Na, max  /(1 + exp([V  m        V  1/2  ]/k)), where   V  m     
is the conditioning pulse voltage,   V  1/2     is the voltage at half-inactivation, 
and k is the slope factor. The whole-cell voltage clamp protocol showing I  Na   
and I  Ca   in   Fig. 5 F   was elicited using the two-pulse paradigm shown in   Fig. 
5 G  . From a holding potential of     100 mV, I  Na   was elicited by a 30-ms 
pulse to     30 mV. The membrane potential was then hyperpolarized to 
    70 mV for 10 ms. I  Ca   was then elicited by a 50-ms pulse to 0 mV. This 
protocol allowed the simple differentiation of I  Na   from I  Ca   as indicated by 
the unique I  Ca   and I  Na   current signatures in   Fig. 5  . All presented currents 
were normalized for cell capacitance. Data were collected and analyzed 
using pCLAMP 9.0 software (MDS Analytical Technologies) and OriginPro 
7.5 (OriginLab Corp.). Analysis of variance was used to compare the 
nominal change in current density among the means. Statistical signiﬁ  -
cance is deﬁ  ned as P   <   0.05. 
  Online supplemental material 
  Fig. S1 demonstrates that cardiomyocytes with reduced ankyrin-G ex-
pression display normal localization and distribution of Cav1.2 and Na/
Ca exchanger. Fig. S2 demonstrates that a full complement of ankyrin-G 
expression is required for normal Nav1.5 expression in adult rat cardio-
myocytes. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200710107/DC1. 
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